Verified factor-similar pair

GRPM vs IQSM

These two ETFs pass the same FF6 US similarity lane: US-listed equity ETFs, same USD model basis, at least one material non-market factor, and 100% overlap in statistically significant material factor exposure.

SMB
Similarity score
84
Verified similar

Score blends exposure-level distance, factor-vector shape, market-beta closeness, and a small backtested relative-Sharpe term.

GRPM

Invesco S&P MidCap 400 GARP ETF
SMB
Adj. R2
0.930
Rel. Sharpe
0.837
Mkt beta
1.02
AUM
US$464M
MER
0.35%
Valuation
127

IQSM

NYLI Candriam U.S. Mid Cap Equity ETF
SMB
Adj. R2
0.921
Rel. Sharpe
0.443
Mkt beta
1.06
AUM
US$312M
MER
0.15%
Valuation
108

Factor Exposure Match

Blue bars compare raw factor beta magnitude. Green bars compare absolute t-stat strength. Dim bars indicate the t-stat is below 1.96.

SMB
GRPM
+0.49
|t|
+10.2
IQSM
+0.43
|t|
+4.1
diff +0.07
HML
GRPM
+0.22
|t|
+4.9
IQSM
+0.21
|t|
+2.0
diff +0.01
RMW
GRPM
+0.16
|t|
+2.8
IQSM
+0.11
|t|
+1.0
diff +0.05
CMA
GRPM
-0.03
|t|
-0.4
IQSM
+0.12
|t|
+0.9
diff -0.15
UMD
GRPM
-0.08
|t|
-2.4
IQSM
-0.06
|t|
-0.9
diff -0.02

Why This Pair Matches

Exposure level
82
Exposure shape
98
Mkt beta diff
0.04
Rel. Sharpe diff
0.394

This comparison focuses on measured factor exposure, not a qualitative review of each fund's portfolio-construction process. Backtested relative Sharpe is included as a secondary signal, while we continue refining a comparison metric that separates factor payoff from alpha. See methodology.

GRPM fund page IQSM fund page US ETF Leaders US Universe
Important context

VerifiedBeta publishes educational ETF research, not personalized investment advice, portfolio management, or security recommendations. Funds that screen well here can still be unsuitable for your objectives, taxes, liquidity needs, or constraints. Review fund documents, methodology assumptions, and your own circumstances before acting. See the full disclaimer.